Literature DB >> 22791325

Urinary biomarkers in autosomal dominant polycystic kidney disease: is there no prognostic value?

Wendy E Boertien, Esther Meijer, Ron T Gansevoort.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22791325     DOI： 10.1038/ki.2012.146

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  2 in total

1.  Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease.

Authors:  Jared J Grantham; Arlene B Chapman; Jaime Blais; Frank S Czerwiec; Olivier Devuyst; Ron T Gansevoort; Eiji Higashihara; Holly Krasa; Wen Zhou; John Ouyang; Ronald D Perrone; Vicente E Torres
Journal:  Nephrol Dial Transplant       Date:  2017-06-01       Impact factor: 5.992

2.  Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression.

Authors:  A Lianne Messchendorp; Esther Meijer; Wendy E Boertien; Gerwin E Engels; Niek F Casteleijn; Edwin M Spithoven; Monique Losekoot; Johannes G M Burgerhof; Dorien J M Peters; Ron T Gansevoort
Journal:  Kidney Int Rep       Date:  2017-10-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.